Home/Filings/4/0001104659-24-084991
4//SEC Filing

Harris Matthew Scott 4

Accession 0001104659-24-084991

CIK 0001326190other

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 5:40 PM ET

Size

13.5 KB

Accession

0001104659-24-084991

Insider Transaction Report

Form 4
Period: 2024-07-31
Harris Matthew Scott
Chief Medical Officer
Transactions
  • Award

    Common Stock, par value $0.0001

    2024-07-31$5.41/sh+1,486$8,03955,119 total
Footnotes (2)
  • [F1]These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from February 1, 2024 through July 31, 2024.
  • [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 31, 2024.

Issuer

Altimmune, Inc.

CIK 0001326190

Entity typeother

Related Parties

1
  • filerCIK 0001787762

Filing Metadata

Form type
4
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 5:40 PM ET
Size
13.5 KB